This document discusses the evaluation and diagnostic approach to anemia in patients with kidney disease. It defines anemia based on hemoglobin levels and describes how frequently hemoglobin should be tested in chronic kidney disease patients, depending on disease severity and treatment. The initial tests recommended for evaluating the cause of anemia include a complete blood count, absolute reticulocyte count, serum ferritin, transferrin saturation, and vitamin B12 and folate levels. Additional potential causes discussed include blood loss, bone disease, infections, and nutritional deficiencies.
Renal disease may produce disturbances in red blood cells, white blood cells, platelets, and coagulation factors
the abnormalities do not parallel the status of renal function but rather reflect the activity of the disease process that results in renal dysfunction.
Renal disease may produce disturbances in red blood cells, white blood cells, platelets, and coagulation factors
the abnormalities do not parallel the status of renal function but rather reflect the activity of the disease process that results in renal dysfunction.
simlpe approach to anemia in children , how to diagnose anemia in kids ,types of anemias ,causes of anemia , iron deficeincy anemia, hemolytic anemias , laboratory tests in anemia ,
simlpe approach to anemia in children , how to diagnose anemia in kids ,types of anemias ,causes of anemia , iron deficeincy anemia, hemolytic anemias , laboratory tests in anemia ,
Anemia of renal disease is common and is associated with significant morbidity and death. It is mainly caused by a decrease in erythropoietin production in the kidneys and can be partially corrected with erythropoiesis-stimulating agents (ESAs). However, randomized controlled trials have shown that using ESAs to target normal hemoglobin levels can be harmful, and have called into question any benefits of ESA treatment other than avoidance of transfusions.
Jay B. Wish, MD, Anil K. Agarwal, MD, FASN, and Thomas C. Dowling, PharmD, PhD, FCCP, prepared useful practice aids pertaining to anemia in CKD for this CPE activity titled "Exploring Emerging Strategies in the Management of Anemia in Chronic Kidney Disease." For the full presentation, monograph, complete CPE information, and to apply for credit, please visit us at http://bit.ly/2PB1tOd. CPE credit will be available until December 30, 2020.
Jay B. Wish, MD, prepared anemia in CKD infographics for this CME activity titled "Addressing Unmet Needs in Managing Anemia in Chronic Kidney Disease: A Closer Look at the Clinical Potential of HIF-PH Inhibitors." For the full presentation, monograph, complete CME information, and to apply for credit, please visit us at http://bit.ly/2WdYNpK. CME credit will be available until June 12, 2020.
Background: Anemia is a common Feature of chronic kidney disease, but the management of anemia in children is complex. Erythropoietin and Supplemental iron are used to maintain hemoglobin levels. The aim of this study to determine the Frequency of anemia and possible Risk Factors Among children with End stage renal disease.
Methods: A total of 96 children, 61males (63.5%) and 35 Females (36.5%), were attended at hemodialysis units in Khartoum state were enrolled in the study and Frequency of anemia was estimated by analyzing CBC on blood counter (sysmex). The concentration of iron profile, C-reactive protein and parathyroid hormone was measured using COBAS INTEGRA 400 PLUS and COBAS E411.
Results: 99% of children were anemic, 4.17% of them were suffering from iron deficiency anemia and there are other causes contributing to anemia in ESRD patients which are inflammation and hyperparathyroidism.
Conclusion: The prevalence of anemia in children on hemodialysis in Sudan appears to be higher than that reported in other studies despite extensive use of rHuEPO and iron supplementation.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
2. 2
often no
symptoms High BP
proteinuria anemia
early bone dis. fatigue , swelling
Nausea , ……. needs renal
replacement therapy
In patients with CKD but stable kidney function,
the appearance or progression of anemia may
herald a new problem that is causing blood loss
or is interfering with red cell production.
3. 3
Anemia is a condition in which the number of RBCs or their oxygen-carrying capacity is insufficient to
meet physiologic needs, which vary by age, sex
4. 4
How to define anemia in CKD
KDIGO 2012 Clinical Practice Guideline for Anemia in Chronic Kidney Disease
In adults and children >15 years with CKD (Not Graded)
Hb<13.0 g/dl in males
Hb<12.0 g/dl in females
In children with CKD (Not Graded)
Hb<11.0 g/dl in children 0.5–5 years
Hb< 11.5 g/dl in children 5–12 years
Hb< 12.0 g/dl in children 12–15 years
5. Frequency of testing for anemia in CKD
5KDIGO 2012 Clinical Practice Guideline for Anemia in Chronic Kidney Disease
CKD adults without anemia
measure Hb concentration when clinically indicated (Not Graded)
at least annually in patients with CKD 3
at least twice per year in patients with CKD 4–5ND
at least every 3 months in patients with CKD 5HD and CKD 5PD
6. Frequency of testing for anemia in CKD
6KDIGO 2012 Clinical Practice Guideline for Anemia in Chronic Kidney Disease
CKD children with anemia not being treated with an ESA
measure Hb concentration when clinically indicated (Not Graded)
at least every 3 months in patients with CKD 3–5ND and CKD 5PD
at least monthly in patients with CKD 5HD
7. 7Hemoglobin decline in children with CKD ,Clin J Am Soc Nephrol 2008; 3: 457–462.
GFR ≅43ml/min /1.73m2
8. Frequency of testing for anemia in CKD
8
CKD patients being treated with ESA
in the initiation phase of ESA therapy, at least monthly. (Not Graded)
for CKD ND patients, during the maintenance phase of ESA therapy ,
at least every 3 months. (Not Graded)
for CKD 5D patients, during the maintenance phase of ESA therapy,
at least monthly
KDIGO 2012 Clinical Practice Guideline for Anemia in Chronic Kidney Disease
9. Investigation of anemia in CKD
9
In patients with CKD and anemia (regardless of age and CKD stage),
include the following tests in initial evaluation of anemia :
CBC (Hb , red cell indices, WBC ( diff) & platelet count)
Absolute reticulocyte count
Serum ferritin level
Serum transferrin saturation (TSAT)
Serum vitamin B12 and folate levels
KDIGO 2012 Clinical Practice Guideline for Anemia in Chronic Kidney Disease
10. CBC
10
Hollowell JG, van Assendelft OW,
Gunter EW et al. Hematological &
iron-related analytes–reference
data for persons aged 1 year and
over: US , 1988-94. Vital Health
Stat 11, 2005, 1–156.
Nathan and Oski’s Hematology of Infancy and
Childhood, 6th edn. WB Saunders: Philadelphia,
PA, 2003, p 1841.
11. 11
Absolute reticulocyte count
Effective erythropoietic proliferative activity is most simply assessed
by determination of the absolute reticulocyte count .
which may be
high in patients who have active blood loss or hemolysis
low in hypoproliferative erythropoiesis with anemia in CKD
12. 12
Iron storage
Ferritin is the most commonly used test
( not gold standard )
- acute phase reactant
- Ferritin value
TSAT is the most commonly used for
availability of iron to support
erythropoiesis.
Other tests of iron status
Sensitivity and specificity of TSAT and serum ferritin &
their combination & also BM iron to identify correctly a
positive erythropoietic response (≥1-g/dl increase in Hb )
to intravenous iron in 100 NHD patients with CKD
J Am Soc Nephrol 2010; 5: 409–416
13. 13
Vitamin B12 & Folate
Uncommon but important causes of easily correctable anemia
prevalence 10% in HD patients but unknown prevalence in CKD
patients
Folate deficiency detection methods
14. 14
Additional tests
may be appropriate in individual patients and in certain specific
clinical settings.
CRP may be indicated if occult inflammation is a concern.
In certain countries and/or in patients of specific nationalities or
ethnicities, testing for hemoglobinopathies, parasites, and ,…..
15. Anemia & kidney
15
Infections such as UTI
Renal cysts
Nephritic syndrome
Renal stones & hematuria
Reflux-Related Renal Injury ???
Nephrotic syndrome
Anemia in nephrotic syndrome: approach to evaluation and
treatment. Pediatr Nephrol. 2017 Aug;32(8):1323-1330
(World Health Organization. Worldwide Prevalence of Anaemia 1993–2005: WHO Global Database on Anaemia. In: de Benoist B, McLean E, Egli I and M Cogswell (eds), 2008.)
Clinically indicated means also such as after a major surgical procedure, hospitalization, or bleeding episode.
Clinically indicated means also such as after a major surgical procedure, hospitalization, or bleeding episode.
Children Prospective Cohort Study (CKiD), which evaluated 340 North American children with CKD using iohexol determined GFR ,in the GFR <43 ml/min per 1.73m2, there was a linear relationship between Hb and GFR, with Hb 0.3 g/dl (3 g/l) lower per 5 ml/min per 1.73m2 lower GFR. Above that threshold, there was a non significant association of 0.1 g/dl (1 g/l) lower Hb for every 5 ml/min per 1.73m2 lower GFR. (Fadrowski JJ, Pierce CB, Cole SR et al. Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol 2008; 3: 457–462.)
Because serum creatinine-based estimated glomerular filtration rate (eGFR) using the Schwartz formula may overestimate the true GFR in the children providers need to consider the potential for Hb decline and anemia even at early stages of CKD and monitor accordingly.(Schwartz GJ, Munoz A, Schneider MF et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629–637.)
ESA = Erythropoiesis-stimulating agent
Severity of anemia is assessed best by measuring Hb concentration rather than hematocrit.
Red cell indexes :
Hypoproliferative, and in general, normochromic and normocytic anemia
Macrocytosis in Folate or vitamin B12 deficiencies
Microcytosis in Iron deficiency or inherited disorders of Hb formation (e.g., a- or b-thalassemia .
Note : Iron deficiency, especially if longstanding, is associated with hypochromia (low MCH)
Note : hematopoiesis caused by toxins (e.g., alcohol), nutritional deficit (vitamin B12 or folate deficiency), or myelodysplasia.
WBC & Platelets :
Macrocytosis with leukopenia or thrombocytopenia suggests a generalized disorder
Note : There are two important and distinct aspects of the assessment of iron status testing: the presence or absence of storage iron and the availability of iron to support ongoing erythropoiesis
‘gold standard’ remains examination of a bone marrow aspiration stained for iron.
TSAT = serum iron × 100 divided by total iron binding capacity
Ferritin is affected by inflammation and is an ‘acute phase reactant’ so , ferritin values have to be interpreted with caution in CKD patients, especially those on dialysis in whom subclinical inflammation may be present and we know iron can deposit in liver in hepatitis C virus infection
Ferritin values ≤30 ng/ml (≤30 mg/l) indicate severe iron deficiency and are highly predictive of absent iron stores in bone marrow.
Ferritin values >30 ng/ml (>30 mg/l), however, do not necessarily indicate the presence of normal or adequate bone marrow iron stores.
Studies assessing ferritin levels above which all or nearly all patients with CKD have normal bone marrow iron stores have produced varied results but most CKD patients, including those who are on HD, will have normal bone marrow iron stores when their serum ferritin level is ≥300 ng/ml (≥300 mg/l). Even at serum ferritin levels of 100 ng/ml (100 mg/l) most CKD patients have stainable bone marrow iron stores.
So the serum ferritin and TSAT values are often used together to assess iron status, diagnose iron deficiency, and predict an erythropoietic response to iron supplementation
Other tests of iron status, such as percentage of hypochromic red blood cells and reticulocyte Hb content may be used instead of, or in addition to, TSAT and ferritin levels if available. Measurement of hepcidin levels has not been shown to be clinically useful or superior to more standard iron status tests in patients with CKD
supplemental iron should be administered to maintain ferritin levels < 200 ng/ml (< 200mg/l) in CKD 5HD patients and< 100 ng/ml (< 100mg/l) in CKD ND and CKD 5PD with TSAT< 20% in all CKD patients.
Evaluate iron status (TSAT and ferritin) at leastevery 3 months during ESA therapy, including thedecision to start or continue iron therapy. (NotGraded)
assessment are generally considered standard components of anemia evaluation, especially in the presence of macrocytosis.
Folate deficiency is best detected in most patients with serum folate level testing; RBC folate levels can be measured when serum folate levels are equivocalor when there is concern that recent dietary intake may obscure underlying folate deficiency using serum levels alone
Guide subsequent iron administration in CKD patients based on Hb responses to recent iron therapy, as well as ongoing blood losses, iron status tests (TSAT and ferritin), Hb concentration, ESA responsiveness and ESA dose in ESA treated patients, trends in each parameter, and the patient’s clinical status. (Not Graded)
excessive urinary losses of iron, transferrin, erythropoietin, transcobalamin and/or metals. This leads to a deficiency of substrates necessary for effective erythropoiesis, requiring supplementation in order to correct the anemia. Supplementation of iron and erythropoietin alone often does not lead to correction of the anemia, suggesting other possible mechanisms which need further investigation.